Empty capsules found, Aurobindo Pharma recalls Gabapentin

After finding out that one lot of Gabapentin Capsules 300 mg had empty capsules, Aurobindo Pharma, US, has recalled the lot.

“Empty capsules could result in missed dose(s) of Gabapentin resulting in adverse health consequences that could range from no effect, short-term reduction in efficacy, short-term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening,’’ the US Food and Drug Administration (USFDA) said in a release on its Web site.

Gabapentin Inhibits Central Sensitization During Migraine, Say Researchers
Excitatory amino acids and protein kinase C are involved in the formation and maintenance of central sensitization during migraine, find researchers.

The product was distributed under the Northstar label to retail outlets. Though no case of adverse event has been reported, four complaints of empty capsules have been received.

“Consumers, distributors, and retailers that have product which is being recalled should stop using, distributing, or dispensing the affected lot and return to place of purchase,” the company advises.

Gabapentin is used for the treatment of epilepsy and manage postherpetic neuralgia.

Good Outcomes With Staged Approach to Epilepsy Surgery in Children
A staged approach to epilepsy surgery —with invasive brain monitoring followed by surgery in a single hospital stay— is a safe and beneficial approach to treatment for complex cases of epilepsy in children.

Source-Medindia

Effective Protection for Brain Cells in Drug Combination
Prolonged seizures known as status epilepticus lead to vital neurological deficits and can even prove to be fatal.

Shingles Vaccine Effective for Both Herpes Zoster and Postherpetic Neuralgia
Though associated with a reduction in both herpes zoster and postherpetic neuralgia, the uptake of shingles vaccine in the US is low.